Gritstone bio

Emeryville, United States

Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

$32.5M raised

Apr 2024

Post-IPO Equity

Biotechnology Health Care Therapeutics

Top Investors

Lilly Asia Ventures Gilead Sciences Redmile Group The Column Group Frazier Healthcare Partners

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Gritstone bio

How much funding has Gritstone bio raised?

Gritstone bio has raised $32.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2024.

Who are Gritstone bio's investors?

Gritstone bio's investors include Lilly Asia Ventures, Gilead Sciences, Redmile Group, The Column Group, Frazier Healthcare Partners.

Where is Gritstone bio headquartered?

Gritstone bio is headquartered in Emeryville, United States.

What does Gritstone bio do?

Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

What stage is Gritstone bio at?

Gritstone bio is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 1, 2024.

MLA

"Gritstone bio — Funding & Investors." VCBacked, April 1, 2024, https://www.vcbacked.co/company/gritstone-bio. Accessed July 2, 2026.

APA

VCBacked. (2024). Gritstone bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/gritstone-bio

Wikipedia (cite web)

{{cite web |title=Gritstone bio — Funding & Investors |url=https://www.vcbacked.co/company/gritstone-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 1, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K